The Spinal Cord Injury (SCI) program entitled “Development of Antisense Therapy of Spinal Cord Injury” has been approved to continue the development by the mid-term evaluation of Japan Agency for Medical Research and Development (AMED).
The program was adapted as the 4th Cyclic Innovation for Clinical Empowerment (CiCLE, Start-up type; ViCLE) by AMED.

Please click here(This link will connect you to AMED website) for more details(Japanese only).